27.01.2022 23:28:00

Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference

NEW BRUNSWICK, N.J., Jan. 27, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visit the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

(PRNewsfoto/Johnson & Johnson)

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-citis-2022-virtual-healthcare-conference-301470256.html

SOURCE Johnson & Johnson

Analysen zu Johnson & Johnsonmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Johnson & Johnson 139,36 -0,04% Johnson & Johnson